Wedbush Comments on Chimerix, Inc.’s Q1 2025 Earnings (NASDAQ:CMRX)
Chimerix, Inc. (NASDAQ:CMRX – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings estimates for shares of Chimerix in a research report issued to clients and investors on Wednesday, May 1st. Wedbush analyst D. Nierengarten forecasts that the biopharmaceutical company will earn ($0.23) per share for the quarter. Wedbush currently has […]
More Stories
Chinese Spy Defector Shares New Info on Dissident Whose ‘Mysterious’ Death in Canada Was Cited as a Warning
By Andrew Chen A former Chinese spy has revealed new information about the Chinese regime’s targeting of a Chinese dissident...
Researchers Discover New Mechanism Linking Diet and Cancer Risk
By Jennifer Sweenie You may have heard that sugar feeds cancer cells, and evidence supports that. However, the missing link...
Conservative Group Files Emergency Court Motion to Get Biden–Hur Audio Tapes
By Tom Ozimek The Heritage Foundation, a conservative think-tank, has filed an emergency motion in a Washington court seeking to...
Gaza: Nearly 800,000 now displaced from Rafah
Roughly 800,000 people have been forced to flee Rafah since Israel launched a military operation in the area on 6...
News from the WHO: Ground-breaking progress made in Member State negotiations on amendments to the International Health Regulations (IHR) https://ift.tt/zIwJ6um May 18, 2024 at 05:00AM
Published on May 18, 2024 at 05:00AM View on website
Fisk Season 3: Release Date, Cast, and Trailer
Fisk, an Australian series, has gone on to win several awards for its stellar cast. With two seasons ahead, fans...